Genome & Company (KOSDAQ: 314130)
South Korea
· Delayed Price · Currency is KRW
2,915.00
-15.00 (-0.51%)
Nov 15, 2024, 9:00 AM KST
-51.90% (1Y)
Market Cap | 90.43B |
Revenue (ttm) | 23.92B |
Net Income (ttm) | -37.88B |
Shares Out | 30.97M |
EPS (ttm) | -1,297.31 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 224,281 |
Open | 2,895.00 |
Previous Close | 2,930.00 |
Day's Range | 2,710.00 - 2,985.00 |
52-Week Range | 2,710.00 - 7,335.00 |
Beta | n/a |
Analysts | n/a |
Price Target | n/a |
Earnings Date | Nov 14, 2024 |